Eliaz Therapetuics


Eliaz Therapeutics is developing a novel treatment using targeted therapeutic apheresis to remove Galetin-3 from the body

Employees

1-10

Links


Org chart

Isaac Eliaz
Founder, CEO & CSO
Collapse
Rajeev Kumar
VP of R&D
Anat Stern
BD & Operation

Board & advisors

David H. Sachs
Scientific Advisor
Daniel Keizman
Scientific Advisor
Patrick M. Moriarty
Scientific Advisor
Jeffrey L. Winters
Scientific Advisor


Offices